MicroRNA and cancer
Tóm tắt
With the advent of next generation sequencing techniques a previously unknown world of non‐coding RNA molecules have been discovered. Non‐coding RNA transcripts likely outnumber the group of protein coding sequences and hold promise of many new discoveries and mechanistic explanations for essential biological phenomena and pathologies. The best characterized non‐coding RNA family consists in humans of about 1400 microRNAs for which abundant evidence have demonstrated fundamental importance in normal development, differentiation, growth control and in human diseases such as cancer. In this review, we summarize the current knowledge and concepts concerning the involvement of microRNAs in cancer, which have emerged from the study of cell culture and animal model systems, including the regulation of key cancer‐related pathways, such as cell cycle control and the DNA damage response. Importantly, microRNA molecules are already entering the clinic as diagnostic and prognostic biomarkers for patient stratification and also as therapeutic targets and agents.
Từ khóa
Tài liệu tham khảo
Feng G., 2008, Elevated serum-circulating RNA in patients with conventional renal cell cancer, Anticancer Res, 28, 321
Frankel L.B. Lund A.H. MicroRNA regulation of Autophagy. Carcinogenesis in press.
Leucci E. Zriwil A. Gregersen L.H. Jensen K.T. Obad S. Bellan C. Leoncini L. Kauppinen S. Lund A.H. Inhibition of miR-9 de-represses HuR and DICER1 and impairs Hodgkin lymphoma tumour outgrowth in vivo. Oncogene in press.
Neilsen P.M. Noll J.E. Mattiske S. Bracken C.P. Gregory P.A. Schulz R.B. Lim S.P. Kumar R. Suetani R.J. Goodall G.J. Callen D.F. Mutant p53 drives invasion in breast tumors through up-regulation of miR-155. Oncogene in press.
Zhang J. Sun Q. Zhang Z. Ge S. Han Z.G. Chen W.T. Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop. Oncogene in press.